Member Info for CHELSEA7

+ 7.86%

And bid rising again.

Back to 22/23 +7.14%

froggy, well if you stay around long enough this will be the new Biontech!!

+5.95%

22.5/23.30 +9.05%

22/23 +7.145

Now 22/22.5

Volume and trades well down on yesterday and must be many delayed sells in background.

Good start though +5.95%

After a few sells, 22p paid many times.....................................going up!!!

21.50/22

21/22 +2.38%

Was six on 21, now two.

Not sure crumbs, but there is plenty of support out there now, and after the initial £2.7m investment we must be very well positioned.

Expecting RNS after confirmation of funding, which could be any day.

Thank you Ivy.

Scancell is calling for more funding to progress its new vaccine through clinical trial - hoping for a large pharmaceutical partner and investment of hundreds of millions of pounds.

""Loving It""

Agree crumbs, there have been four trades already this morning by 7.16, trades unkown as yet.

Perhaps we will open higher again 21/22 perhaps, and Ruck just my opinion but I can see a good 25% rise today, which would take us back to 26/27 close to yesterdays spike. I think many will feel the retrace from 28p affords a good entry point now. Expecting a huge volume again today, I believe yesterday was some way over 60m the biggest volume I have seen.

Thank you very much Ruck, hope you are doing well. ATB

Many options going on out there, and IMHO I bekieve we are are as far as talks with the Government on future funding for our Phase 1 trial..........................

The Company has previously stated it would require additional funding to advance SDC-1801 into clinical trials depending both on positive results from its ongoing Covid-19 research programme and on the successful outcome of the Company's broader preclinical development programme with SDC-1801. The Company believes that, should the current preclinical work programme be successful and indicate that SDC-1801 is a potential treatment for severe-phase Covid-19, the Company may be eligible for an AGILE grant.

Sareum's CSO, Dr John Reader, commented :

"We are delighted that the UK government has created the AGILE clinical trial platform and has provided the funding needed to support this exciting and much needed initiative, which may represent a potential route of future funding for the Company. Despite the successful UK vaccination programme, we believe that there is still a clear need for new therapies to treat severe respiratory inflammation arising from viral infections such as Covid-19. Should the Company's current work programme be successful, we will consider this new initiative as a potential source of funding contributing towards advancing SDC-1801 as a potential treatment for Covid-19 patients."

The Company notes that at the recent launch of the AGILE clinical trial platform, Health and Social Care Secretary, Matt Han****, said:

" Today's news will ensure all phases of clinical trials for new treatments are done in the UK, protecting our supply chain and securing the world's best treatments for NHS patients at a much faster rate. I am immensely proud of the work that's been undertaken by the brilliant scientists behind these treatments and the thousands of UK patients who have taken part in the trials. Together, we can continue to ensure the UK is one of the best countries in the world for trialling and deploying the most ground-breaking medical advancements for both COVID-19 and for dangerous diseases in the future."

Think I mentioned late last night that I stumbled on yesterdays RNS late in the evening and felt another high just reading the content. It was hardly a reason for rise RNS, but a very well worded every reason for rise and the only negative anyone could of had i.e timelines for trial, were very robustly answered IMHO. Anyone got any further thoughts on that?

Morning LL, and all the better for seeing you too.

Kind of lost where you are posting now mainly, I just don"t use twitter, and in the few hours I am up in each day find it hard just keeping up with e-mails alone.

You must be delighted with the developments of late here, , a very exciting time, hard to imagine we are the same share that was trading at 5.5p this time last year. I certainly bought a few then to get my average down to under 13.5 now, but TBH lacked the confidence and funds then to truly benefit from it. At last I feel as if we are an AIM share with all that comes with it, and at last it was us showing 102% up by 9 yesterday morning.

With the expected revenues that we could bring in, the validation of the Immunody platform I can see a real hope that we could join the NASDAQ within 2 years. The factors against it were the costs and being relatively unknown, well after our second media blitz and no signs of letting up, I think both of those issues are being sorted out, the future is looking bright and that was simply reflected by our rise yesterday.

Here"s to many more, Take care of yourself and not too far my first target 50p now. ATVB

Morning Hasiba, wading my way through yesterdays posts, missing posts is never an option for me, there is always something to learn or just dismiss on research we have done for ourselves. Never a truer comment than DYOR, but something terrific about this BB is the amount of posters who unearth such interesting links so we can narrow down where to look to research and form opinions.

Hasiba, your post last night.........................

hasiba

Posts: 3,931

Price: 21.00

No Opinion

RE: Evening GuysMon 20:03
C7...glad to hear your good news and being out of worries ...
With very best wishes..
Now back to business and waiting to see your views of our beloved SCLP..

ReplyRecommend (4)Report Post

Hasiba, thank you very much for your good wishes, one of the big plusses to this BB has been having you posting here for the last year. I trust you now know my feelings for now on Scancell today, my feelings just get stronger every passing day, and the opportunity like Biontech has come to us to trial and get approved in a short time a Universal Vaccine which has the potential to bring in our first income stream, in fact a huge one.

What with the recent fund raise from Redmile and Vulpes money, the monkey in the room, is for the first time not our issue, we have enough to take our platforms much further in clinical trials, but what with delays initiating trials what an opportunity we have to secure our first Approved Product (like Biontech) and I am sure human resources have been maximised to this platform.

I have enjoyed your posts very much, informative, honest and polite, never one to be drawn into the nonsense we have to see here on occasions, and I would suggest that LTH and Newbies alike look back on your posts the last few months. They have been uncannily correct even your timelines, and I urge others to read them and look forward as much as you do to sharing our thoughts in the future. ATVB Buddy